Common Stock, Value, Issued in USD of Regencell Bioscience Holdings Ltd from Q2 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Regencell Bioscience Holdings Ltd quarterly Common Stock, Value, Issued history and change rate from Q2 2020 to Q2 2025.
  • Regencell Bioscience Holdings Ltd Common Stock, Value, Issued for the quarter ending 30 Jun 2025 was $4.95K, a 3704% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Change (%)

Regencell Bioscience Holdings Ltd Quarterly Common Stock, Value, Issued (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $4.95K +$4.82K +3704% 30 Jun 2025 20-F 31 Oct 2025
Q2 2024 $130 $0 0% 30 Jun 2024 20-F 31 Oct 2025
Q2 2023 $130 $0 0% 30 Jun 2023 20-F 25 Oct 2024
Q2 2022 $130 +$30.00 +30% 30 Jun 2022 20-F 27 Oct 2023
Q2 2021 $100 $0 0% 30 Jun 2021 20-F 31 Oct 2022
Q2 2020 $100 30 Jun 2020 20-F 29 Oct 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.